BioSig Technologies: New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
WESTPORT, CT / ACCESSWIRE / May 25, 2023 / Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies' (NASDAQ:BSGM) proprietary PURE EP Platform at the annual Heart
United States Gewinn Nur Biosense Webster Biosig Technologiesview Ali Hajiluyi Centers For Disease Control
Source: finanznachrichten.de